<DOC>
	<DOCNO>NCT00346294</DOCNO>
	<brief_summary>An open-label , single arm study estimate rate failure Enbrel® SureClick™ Auto-injector RA subject .</brief_summary>
	<brief_title>An Open-Label Study Assess Rate Failure Enbrel® ( Etanercept ) SureClick™ Auto-Injector Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis rheumatoid arthritis RA subject 18 year old Currently take etanercept prefilled syrinx least 4 week Subjects must give write informed consent Subjects must able read write English Subject use adequate contraception Subject pregnant breast feeding Significant concurrent medical disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Device</keyword>
	<keyword>Auto-injector</keyword>
	<keyword>SureClick</keyword>
	<keyword>Enbrel</keyword>
	<keyword>Etanercept</keyword>
</DOC>